Evidence map›Paper›PMID 37510069›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Comparative Evaluation of Breast Ductal Carcinoma Grading: A Deep-Learning Model and General Pathologists' Assessment Approach.

Maria Magdalena Köteles, Alon Vigdorovits, Darshan Kumar, Ioana-Maria Mihai, Aura Jurescu, Adelina Gheju, Adeline Bucur, Octavia Oana Harich, Gheorghe-Emilian Olteanu

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Maria Magdalena KötelesBihor County Clinical Emergency Hospital, Gh. Doja Street No. 65, 410169 Oradea, Romania.
Alon VigdorovitsBihor County Clinical Emergency Hospital, Gh. Doja Street No. 65, 410169 Oradea, Romania.ORCID 0000-0002-2923-6813
Darshan KumarAiforia Technologies PLC, 00150 Helsinki, Finland.ORCID 0000-0001-5371-1779
Ioana-Maria MihaiDepartment of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.ORCID 0000-0003-0617-4178
Aura JurescuDepartment of Microscopic Morphology-Morphopatology, ANAPATMOL Research Center, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania.ORCID 0000-0002-0898-795X
Adelina GhejuEmergency County Hospital Deva, Bulevardul 22 Decembrie 58, 330032 Deva, Romania.ORCID 0000-0002-0060-1805
Adeline BucurDepartment of Microscopic Morphology, Discipline of Histology, "Victor Babes" University of Medicine and Pharmacy, Timisoara Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.
Octavia Oana HarichDepartment of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, Timisoara Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.
Gheorghe-Emilian OlteanuCenter for Research and Innovation in Personalized Medicine of Respiratory Diseases, "Victor Babes" University of Medicine and Pharmacy, Timisoara Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania.ORCID 0000-0001-5921-4634
Victor Babeș University of Medicine and Pharmacy Timișoara · ROClinical Emergency Hospital Bucharest · RORaytheon Technologies (Finland) · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most prevalent neoplasia among women, with early and accurate diagnosis critical for effective treatment. In clinical practice, however, the subjective nature of histological grading of infiltrating ductal adenocarcinoma of the breast (DAC-NOS) often leads to inconsistencies among pathologists, posing a significant challenge to achieving optimal patient outcomes. Our study aimed to address this reproducibility problem by leveraging artificial intelligence (AI). We trained a deep-learning model using a convolutional neural network-based algorithm (CNN-bA) on 100 whole slide images (WSIs) of DAC-NOS from the Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) dataset. Our model demonstrated high precision, sensitivity, and F1 score across different grading components in about 17.5 h with 19,000 iterations. However, the agreement between the model's grading and that of general pathologists varied, showing the highest agreement for the mitotic count score. These findings suggest that AI has the potential to enhance the accuracy and reproducibility of breast cancer grading, warranting further refinement and validation of this approach.

Indexed as

artificial intelligence in cancer gradingbreast cancerconvolutional neural network-based algorithmdeep-learning modelinfiltrating ductal adenocarcinomaobserver agreement (AI and pathologists)

Identifiers

PMID37510069
PMCPMC10377791
OpenAlexW4383877331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.